VKTX
Viking Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.53 / 10
Netural
Money flow is rated 7.88/10, with positive Small, Medium, and Large inflows but negative overall and block trends, hinting at institutional caution. Analyst coverage is moderate (3 active analysts, 4 recent ratings), with a 4.50 average and high historical win rates for some institutions (e.g., JP Morgan 100%). However, the overall mismatch between falling price and bullish expectations underscores skepticism. Together, sentiment and flow paint a picture of short-term resistance despite medium-term optimism.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-12
InstitutionCanaccord Genuity
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for VKTX?
- VKTX holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.53/10 (Netural).
